Epigenetic reader domain inhibitor (+)-JQ1 PA, Purity ≥98%

Cat. No.: X24-05-ZQ406

Epigenetic reader domain inhibitor (+)-JQ1 PA, Purity ≥98%

Synonym: 2115701-93-2; (+)-JQ1 PA; (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(prop-2-yn-1-yl)acetamide; Epigenetic reader domain inhibitor

  • CAS Number: 2115701-93-2
  • Compound CID: 134821687
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
(+)-JQ1 PA disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
437.95
Molecular Formula
C22H20ClN5OS
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
(+)-JQ1 PA is used to investigate the selective inhibition of BET bromodomains, aiding in the study of gene expression regulation and potential therapeutic applications.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0